YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
<p>Abstract</p> <p>Several inflammatory cytokines are involved in vascular inflammation resulting in endothelial dysfunction which is the earliest event in the atherosclerotic process leading to manifest cardiovascular disease. YKL-40 is an inflammatory glycoprotein involved in end...
Main Authors: | Rathcke Camilla, Vestergaard Henrik |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-01-01
|
Series: | Cardiovascular Diabetology |
Online Access: | http://www.cardiab.com/content/8/1/61 |
Similar Items
-
Increased levels of the calcification marker Matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease
by: Zerahn Bo, et al.
Published: (2010-12-01) -
Variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and prediction of fatal and non-fatal ischemic stroke.
by: Camilla Noelle Rathcke, et al.
Published: (2012-01-01) -
Associations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 Diabetes.
by: Stine B Thomsen, et al.
Published: (2015-01-01) -
The Association between genetic variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and the lipid profile in a Danish population.
by: Stine Brinkløv Thomsen, et al.
Published: (2012-01-01) -
YKL-40 levels are independently associated with albuminuria in type 2 diabetes
by: Vestergaard Henrik, et al.
Published: (2011-06-01)